(주)이언메딕스 / AEONMEDIX
AEONMEDIX's KOBDi Score is 25.06 as of Sep 2026, down 4.81 points since Apr 2025; it fell in 1 of the 12 monthly updates and never rose. As of Sep 2026 it is ahead of about 27% of companies in its industry, against 27% in Aug 2026 and 41% in Apr 2025. Its strongest position was 43% (May 2025) and its weakest 27% (Sep 2026).
A year earlier, in Aug 2025, its score was 29.88 and it was ahead of about 39% of companies in its industry.
| Sep 2026 | 25.06 | ahead of 27% |
| Aug 2026 | 25.06 | ahead of 27% |
| Jul 2026 | 25.06 | ahead of 28% |
| Jun 2026 | 25.06 | ahead of 28% |
| May 2026 | 25.06 | ahead of 28% |
| Apr 2026 | 25.06 | ahead of 28% |
| Mar 2026 | 25.06 | ahead of 28% |
| Feb 2026 | 25.06 | ahead of 29% |
| Dec 2025 | 25.06 | ahead of 29% |
| Aug 2025 | 29.88 | ahead of 39% |
| Jul 2025 | 29.88 | ahead of 42% |
| May 2025 | 29.88 | ahead of 43% |
| Apr 2025 | 29.88 | ahead of 41% |
Where is AEONMEDIX located?
AEONMEDIX is registered at 경상북도 포항시 남구 지곡로, South Korea (postal code 37668).
What industry is AEONMEDIX in?
AEONMEDIX belongs to Professional, Scientific & Technical Services › Research & Development Services › Medical and pharmaceutical research and development industry.
How many employees does AEONMEDIX have?
AEONMEDIX has 1–4 employees.
What is AEONMEDIX's KOBDi Score?
25.06 as of September 2026, ahead of about 27% of companies in its industry.
Who are AEONMEDIX's competitors?
Similar companies include NOAHM, Frontbio and Smart SCO.

